TheraRadar
← Back
Data updated: Mar 29, 2026

FDC LTD

Infectious DiseaseDermatologyCardiovascular
Generics

FDC LTD is a generic drug manufacturer focused on Infectious Disease, Dermatology, Cardiovascular.

2008
Since
11
Drugs
-
Trials
87
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

LATANOPROST 2026-01-30
Labeling
LATANOPROST 2026-01-30
Labeling
LATANOPROST 2026-01-30
Labeling
FLUCONAZOLE 2026-01-08
OLOPATADINE HYDROCHLORIDE 2026-01-06
CIPROFLOXACIN HYDROCHLORIDE 2025-12-17
Labeling
LATANOPROST 2025-12-17
PILOCARPINE HYDROCHLORIDE 2025-10-02
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 25%
2 drugs
Dermatology 25%
2 drugs
Cardiovascular 25%
2 drugs
Respiratory 13%
1 drugs
Neurology 13%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

LEDERLE big-pharma
Infectious Disease, Cardiovascular, Neurology, Dermatology, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Respiratory
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Respiratory
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
PAI HOLDINGS PHARM big-pharma
Dermatology, Infectious Disease, Neurology, Cardiovascular